C07C 317/22
With sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic
Official title: with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
C07C317/22 (With sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic) appears on 508 US grants and 413 published applications in this corpus.
Search patents in C07C- Granted patents
- 508
- Published applications
- 413
- Assignees
- 291
- Inventors
- 1,642
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 3 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 7 | 0 |
| 1982 | 2 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 6 | 0 |
| 1990 | 7 | 0 |
| 1991 | 11 | 0 |
| 1992 | 16 | 0 |
| 1993 | 14 | 0 |
| 1994 | 12 | 0 |
| 1995 | 21 | 0 |
| 1996 | 7 | 0 |
| 1997 | 21 | 0 |
| 1998 | 21 | 0 |
| 1999 | 10 | 0 |
| 2000 | 15 | 0 |
| 2001 | 13 | 10 |
| 2002 | 10 | 14 |
| 2003 | 16 | 27 |
| 2004 | 12 | 25 |
| 2005 | 9 | 21 |
| 2006 | 9 | 27 |
| 2007 | 12 | 16 |
| 2008 | 13 | 26 |
| 2009 | 19 | 24 |
| 2010 | 22 | 13 |
| 2011 | 13 | 18 |
| 2012 | 20 | 15 |
| 2013 | 20 | 5 |
| 2014 | 14 | 17 |
| 2015 | 6 | 22 |
| 2016 | 9 | 14 |
| 2017 | 25 | 16 |
| 2018 | 9 | 13 |
| 2019 | 10 | 15 |
| 2020 | 10 | 11 |
| 2021 | 10 | 9 |
| 2022 | 7 | 12 |
| 2023 | 8 | 12 |
| 2024 | 10 | 16 |
| 2025 | 5 | 13 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Synthetic pathway to belzutifan18 Aug 2026US 12,709,595 B2Merck Sharp & Dohme Corp.
- Compounds and photoresist compositions including the same16 Jun 2026US 12,656,679 B2Dupont Electronic Materials International, LLC
- Arylamides and methods of use thereof26 May 2026US 12,637,414 B2Genzyme Corporation
- Prostaglandin EP4 receptor antagonist compounds19 Aug 2025US 12,391,641 B2Nxera Pharma UK Limitied
- Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof15 Jul 2025US 12,358,870 B2Peloton Therapeutics, Inc.
- Processes of producing volixibat and analogs thereof24 Sep 2026US 2026/0285895 A1Mirum Pharmaceuticals, Inc.
- Prostaglandin ep4 receptor antagonist compounds15 Jan 2026US 2026/0015314 A1
- Solid dispersions and pharmaceutical compositions comprising a substituted indane and methods for the preparation and use thereof23 Oct 2025US 2025/0326711 A1Peloton Therapeutics, Inc.
- Ssao inhibitors and use thereof23 Oct 2025US 2025/0326721 A1Eccogene Inc.
- Composition for forming film, method for forming organic film, patterning process, monomer, and polymer2 Oct 2025US 2025/0306464 A1Shin-Etsu Chemical Co., Ltd.
Most cited
By later US patents
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997
- Electrolyte materials containing highly dissociated metal ion salts168US 5,538,812 AMoltech Corporation · 1996
- Benzene compound having 2 or more substituents87US 7,923,573 B2Daiichi Sankyo Company, Limited · 2011
- 1,2 diarylcyclopentenyl compounds for the treatment of inflammation74US 5,344,991 AG. D. Searle & Co. · 1994
- Substituted spiro compounds for the treatment of inflammation65US 5,393,790 AG. D. Searle & Co. · 1995